10-K Filing

Astrana Health, Inc. CIK: 1083446 FY 2022

Filing Information

Form Type	10-K
Accession Number	`0001628280-23-005871`
Period End Date	20221231
Filing Date	20230301
Fiscal Year	2022
Fiscal Period	FY
XBRL Instance	ameh-20221231_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 107 Income Statement 60 Cash Flow Statement 210 Stockholders Equity 47

Balance Sheet 107 line items

Line Item	Tag	Value	Unit	Period
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$288.03M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$233.10M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$193.47M	USD	Point-in-time
Investment in marketable securities	`MarketableSecuritiesCurrent`	$53.42M	USD	Point-in-time
Investment in marketable securities	`MarketableSecuritiesCurrent`	$5.57M	USD	Point-in-time
Receivables, net	`AccountsReceivableNetCurrent`	$52.63M	USD	Point-in-time
Receivables, net	`AccountsReceivableNetCurrent`	$10.61M	USD	Point-in-time
Receivables, net related parties	`AccountsReceivableRelatedPartiesCurrent`	$69.38M	USD	Point-in-time
Receivables, net related parties	`AccountsReceivableRelatedPartiesCurrent`	$65.15M	USD	Point-in-time
Income taxes receivable	`IncomeTaxesReceivable`	-	USD	Point-in-time
Income taxes receivable	`IncomeTaxesReceivable`	$4.01M	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Other receivables	`OtherReceivablesNetCurrent`	$9.65M	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Other receivables	`OtherReceivablesNetCurrent`	$1.83M	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$18.64M	USD	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	100.00M	shares	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$14.80M	USD	Point-in-time
Common stock, shares outstanding (in shares)	`SharesOutstanding`	46.58M	shares	Point-in-time
Loans receivable	`NotesAndLoansReceivableNetCurrent`	-	USD	Point-in-time
Loans receivable	`NotesAndLoansReceivableNetCurrent`	$996.00K	USD	Point-in-time
Common stock, shares outstanding (in shares)	`SharesOutstanding`	44.63M	shares	Point-in-time
Loans receivable - related party	`NotesReceivableRelatedPartiesCurrent`	$2.12M	USD	Point-in-time
Loans receivable - related party	`NotesReceivableRelatedPartiesCurrent`	$4.00M	USD	Point-in-time
Treasury stock, common, shares (in shares)	`TreasuryStockCommonShares`	10.93M	shares	Point-in-time
Treasury stock, common, shares (in shares)	`TreasuryStockCommonShares`	10.30M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$398.78M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$435.14M	USD	Point-in-time
Assets	`Assets`	$963.90M	USD	Point-in-time
Assets	`Assets`	$852.36M	USD	Point-in-time
Liabilities	`Liabilities`	$395.21M	USD	Point-in-time
Liabilities	`Liabilities`	$336.36M	USD	Point-in-time
Land, property and equipment, net	`PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization`	$108.54M	USD	Point-in-time
Land, property and equipment, net	`PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization`	$53.19M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$76.86M	USD	Point-in-time
Intangible assets, net	`IntangibleAssetsNetExcludingGoodwill`	$82.81M	USD	Point-in-time
Goodwill	`Goodwill`	$275.68M	USD	Point-in-time
Goodwill	`Goodwill`	$239.05M	USD	Point-in-time
Goodwill	`Goodwill`	$253.04M	USD	Point-in-time
Loans receivable	`NotesAndLoansReceivableNetNoncurrent`	$569.00K	USD	Point-in-time
Loans receivable	`NotesAndLoansReceivableNetNoncurrent`	-	USD	Point-in-time
Investments in other entities equity method	`EquityMethodInvestments`	$40.30M	USD	Point-in-time
Investments in other entities equity method	`EquityMethodInvestments`	$41.72M	USD	Point-in-time
Investments in privately held entities	`InvestmentInPrivatelyHeldEntityThatDoesNotReportNetAssetValue`	$896.00K	USD	Point-in-time
Investments in privately held entities	`InvestmentInPrivatelyHeldEntityThatDoesNotReportNetAssetValue`	$896.00K	USD	Point-in-time
Operating lease right-of-use assets	`OperatingLeaseRightOfUseAsset`	$15.44M	USD	Point-in-time
Operating lease right-of-use assets	`OperatingLeaseRightOfUseAsset`	$20.44M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$5.93M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$6.06M	USD	Point-in-time
Total non-current assets	`AssetsNoncurrent`	$528.77M	USD	Point-in-time
Total non-current assets	`AssetsNoncurrent`	$453.58M	USD	Point-in-time
Total assets	`Assets`	$963.90M	USD	Point-in-time
Total assets	`Assets`	$852.36M	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$43.95M	USD	Point-in-time
Accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$49.56M	USD	Point-in-time
Fiduciary accounts payable	`FiduciaryAccountsPayableCurrent`	$8.06M	USD	Point-in-time
Fiduciary accounts payable	`FiduciaryAccountsPayableCurrent`	$10.53M	USD	Point-in-time
Medical liabilities	`LiabilityForClaimsAndClaimsAdjustmentExpense`	$84.25M	USD	Point-in-time
Medical liabilities	`LiabilityForClaimsAndClaimsAdjustmentExpense`	$55.78M	USD	Point-in-time
Medical liabilities	`LiabilityForClaimsAndClaimsAdjustmentExpense`	$50.33M	USD	Point-in-time
Income taxes payable	`AccruedIncomeTaxesCurrent`	-	USD	Point-in-time
Income taxes payable	`AccruedIncomeTaxesCurrent`	$652.00K	USD	Point-in-time
Dividend payable	`DividendsPayableCurrent`	$556.00K	USD	Point-in-time
Dividend payable	`DividendsPayableCurrent`	$664.00K	USD	Point-in-time
Finance lease liabilities	`FinanceLeaseLiabilityCurrent`	$594.00K	USD	Point-in-time
Finance lease liabilities	`FinanceLeaseLiabilityCurrent`	$486.00K	USD	Point-in-time
Operating lease liabilities	`OperatingLeaseLiabilityCurrent`	$2.63M	USD	Point-in-time
Operating lease liabilities	`OperatingLeaseLiabilityCurrent`	$3.57M	USD	Point-in-time
Current portion of long-term debt	`LongTermDebtCurrent`	$619.00K	USD	Point-in-time
Current portion of long-term debt	`LongTermDebtCurrent`	$780.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$115.37M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$147.33M	USD	Point-in-time
Deferred tax liability	`DeferredIncomeTaxLiabilitiesNet`	$9.13M	USD	Point-in-time
Deferred tax liability	`DeferredIncomeTaxLiabilitiesNet`	$3.04M	USD	Point-in-time
Finance lease liabilities, net of current portion	`FinanceLeaseLiabilityNoncurrent`	$973.00K	USD	Point-in-time
Finance lease liabilities, net of current portion	`FinanceLeaseLiabilityNoncurrent`	$1.27M	USD	Point-in-time
Operating lease liabilities, net of current portion	`OperatingLeaseLiabilityNoncurrent`	$13.20M	USD	Point-in-time
Operating lease liabilities, net of current portion	`OperatingLeaseLiabilityNoncurrent`	$19.91M	USD	Point-in-time
Long-term debt, net of current portion and deferred financing costs	`LongTermDebtNoncurrent`	$203.39M	USD	Point-in-time
Long-term debt, net of current portion and deferred financing costs	`LongTermDebtNoncurrent`	$182.92M	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$14.78M	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$20.26M	USD	Point-in-time
Total non-current liabilities	`LiabilitiesNoncurrent`	$247.88M	USD	Point-in-time
Total non-current liabilities	`LiabilitiesNoncurrent`	$220.99M	USD	Point-in-time
Total liabilities	`Liabilities`	$395.21M	USD	Point-in-time
Total liabilities	`Liabilities`	$336.36M	USD	Point-in-time
Commitments and contingencies (Note 14)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Note 14)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Non-controlling interest in Allied Physicians of California, a Professional Medical Corporation (APC)	`TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests`	$13.68M	USD	Point-in-time
Non-controlling interest in Allied Physicians of California, a Professional Medical Corporation (APC)	`TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests`	$55.51M	USD	Point-in-time
Common stock, par value $0.001; 100,000,000 shares authorized, 46,575,699 and 44,630,873 shares outstanding, excluding 10,299,259 and 10,925,702 treasury shares, at December 31, 2022 and 2021, respectively	`CommonStockValue`	$47.00K	USD	Point-in-time
Common stock, par value $0.001; 100,000,000 shares authorized, 46,575,699 and 44,630,873 shares outstanding, excluding 10,299,259 and 10,925,702 treasury shares, at December 31, 2022 and 2021, respectively	`CommonStockValue`	$45.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$360.10M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$310.88M	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$143.63M	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$192.68M	USD	Point-in-time
Stockholders' equity attributable to parent	`StockholdersEquity`	$454.55M	USD	Point-in-time
Stockholders' equity attributable to parent	`StockholdersEquity`	$552.82M	USD	Point-in-time
Non-controlling interest	`MinorityInterest`	$2.19M	USD	Point-in-time
Non-controlling interest	`MinorityInterest`	$5.94M	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$192.34M	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$555.01M	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$330.91M	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$460.49M	USD	Point-in-time
Total liabilities, mezzanine equity, and stockholders equity	`LiabilitiesAndStockholdersEquity`	$852.36M	USD	Point-in-time
Total liabilities, mezzanine equity, and stockholders equity	`LiabilitiesAndStockholdersEquity`	$963.90M	USD	Point-in-time

Income Statement 60 line items

Line Item	Tag	Value	Unit	Period
Total revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	$687.18M	USD	Annual
Total revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	$773.91M	USD	Annual
Total revenue	`RevenueFromContractWithCustomerExcludingAssessedTax`	$1.14B	USD	Annual
Cost of services, excluding depreciation and amortization	`CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization`	$539.21M	USD	Annual
Cost of services, excluding depreciation and amortization	`CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization`	$596.14M	USD	Annual
Cost of services, excluding depreciation and amortization	`CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization`	$944.68M	USD	Annual
General and administrative expenses	`GeneralAndAdministrativeExpense`	$62.08M	USD	Annual
General and administrative expenses	`GeneralAndAdministrativeExpense`	$49.12M	USD	Annual
General and administrative expenses	`GeneralAndAdministrativeExpense`	$77.67M	USD	Annual
Depreciation and amortization	`CostOfGoodsAndServicesSoldDepreciationAndAmortization`	$18.35M	USD	Annual
Depreciation and amortization	`CostOfGoodsAndServicesSoldDepreciationAndAmortization`	$17.52M	USD	Annual
Depreciation and amortization	`CostOfGoodsAndServicesSoldDepreciationAndAmortization`	$17.54M	USD	Annual
Total expenses	`CostsAndExpenses`	$1.04B	USD	Annual
Total expenses	`CostsAndExpenses`	$606.68M	USD	Annual
Total expenses	`CostsAndExpenses`	$675.74M	USD	Annual
Income from operations	`OperatingIncomeLoss`	$80.50M	USD	Annual
Income from operations	`OperatingIncomeLoss`	$98.18M	USD	Annual
Income from operations	`OperatingIncomeLoss`	$104.27M	USD	Annual
Income (loss) from equity method investments	`IncomeLossFromEquityMethodInvestments`	$5.62M	USD	Annual
Income (loss) from equity method investments	`IncomeLossFromEquityMethodInvestments`	$3.69M	USD	Annual
Income (loss) from equity method investments	`IncomeLossFromEquityMethodInvestments`	$-4.31M	USD	Annual
Gain on sale of equity method investment	`EquityMethodInvestmentRealizedGainLossOnDisposal`	-	USD	Annual
Gain on sale of equity method investment	`EquityMethodInvestmentRealizedGainLossOnDisposal`	$99.84M	USD	Annual
Gain on sale of equity method investment	`EquityMethodInvestmentRealizedGainLossOnDisposal`	$2.19M	USD	Annual
Interest expense	`InterestExpense`	$9.50M	USD	Annual
Interest expense	`InterestExpense`	$5.39M	USD	Annual
Interest expense	`InterestExpense`	$7.92M	USD	Annual
Interest income	`InvestmentIncomeInterest`	$1.98M	USD	Annual
Interest income	`InvestmentIncomeInterest`	$1.57M	USD	Annual
Interest income	`InvestmentIncomeInterest`	$2.81M	USD	Annual
Unrealized loss on investments	`UnrealizedGainLossOnInvestments`	$-21.27M	USD	Annual
Unrealized loss on investments	`UnrealizedGainLossOnInvestments`	-	USD	Annual
Unrealized loss on investments	`UnrealizedGainLossOnInvestments`	$-10.74M	USD	Annual
Other income (expense)	`OtherNonoperatingIncomeExpense`	$1.08M	USD	Annual
Other income (expense)	`OtherNonoperatingIncomeExpense`	$-3.75M	USD	Annual
Other income (expense)	`OtherNonoperatingIncomeExpense`	$3.94M	USD	Annual
Total other (expense) income, net	`NonoperatingIncomeExpense`	$97.92M	USD	Annual
Total other (expense) income, net	`NonoperatingIncomeExpense`	$-20.43M	USD	Annual
Total other (expense) income, net	`NonoperatingIncomeExpense`	$-17.65M	USD	Annual
Income before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$77.75M	USD	Annual
Income before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$178.43M	USD	Annual
Income before provision for income taxes	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$86.62M	USD	Annual
Provision for income taxes	`IncomeTaxExpenseBenefit`	$56.11M	USD	Annual
Provision for income taxes	`IncomeTaxExpenseBenefit`	$36.09M	USD	Annual
Provision for income taxes	`IncomeTaxExpenseBenefit`	$28.45M	USD	Annual
Net income	`ProfitLoss`	$49.29M	USD	Annual
Net income	`ProfitLoss`	$122.32M	USD	Annual
Net income	`ProfitLoss`	$50.53M	USD	Annual
Net income (loss) attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$-24.56M	USD	Annual
Net income (loss) attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$84.45M	USD	Annual
Net income (loss) attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$1.48M	USD	Annual
Net income attributable to Apollo Medical Holdings, Inc.	`NetIncomeLoss`	$49.05M	USD	Annual
Net income attributable to Apollo Medical Holdings, Inc.	`NetIncomeLoss`	$37.87M	USD	Annual
Net income attributable to Apollo Medical Holdings, Inc.	`NetIncomeLoss`	$73.86M	USD	Annual
Earnings per share basic (in dollars per share)	`EarningsPerShareBasic`	$1.09	USD	Annual
Earnings per share basic (in dollars per share)	`EarningsPerShareBasic`	$1.04	USD	Annual
Earnings per share basic (in dollars per share)	`EarningsPerShareBasic`	$1.69	USD	Annual
Earnings per share diluted (in dollars per share)	`EarningsPerShareDiluted`	$1.01	USD	Annual
Earnings per share diluted (in dollars per share)	`EarningsPerShareDiluted`	$1.08	USD	Annual
Earnings per share diluted (in dollars per share)	`EarningsPerShareDiluted`	$1.63	USD	Annual

Cash Flow Statement 210 line items

Line Item	Tag	Value	Unit	Period
Net income	`ProfitLoss`	$49.29M	USD	Annual
Net income	`ProfitLoss`	$122.32M	USD	Annual
Net income	`ProfitLoss`	$50.53M	USD	Annual
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$17.52M	USD	Annual
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$18.35M	USD	Annual
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$17.54M	USD	Annual
Amortization of debt issuance cost	`AmortizationOfFinancingCosts`	$1.35M	USD	Annual
Amortization of debt issuance cost	`AmortizationOfFinancingCosts`	$939.00K	USD	Annual
Amortization of debt issuance cost	`AmortizationOfFinancingCosts`	$1.08M	USD	Annual
Share-based compensation	`ShareBasedCompensation`	$16.10M	USD	Annual
Share-based compensation	`ShareBasedCompensation`	$3.38M	USD	Annual
Share-based compensation	`ShareBasedCompensation`	$6.75M	USD	Annual
Gain on sale of investments	`GainOnSaleOfInvestments`	$2.19M	USD	Annual
Gain on sale of investments	`GainOnSaleOfInvestments`	$2.27M	USD	Annual
Gain on sale of investments	`GainOnSaleOfInvestments`	$99.84M	USD	Annual
Loss (gain) on consolidation of equity method investment	`GainLossOnConsolidationOfEquityMethodInvestment`	-	USD	Annual
Loss (gain) on consolidation of equity method investment	`GainLossOnConsolidationOfEquityMethodInvestment`	$2.75M	USD	Annual
Loss (gain) on consolidation of equity method investment	`GainLossOnConsolidationOfEquityMethodInvestment`	$-901.00K	USD	Annual
Gain on contingent equity securities	`GainLossOnEquityReceivable`	-	USD	Annual
Gain on contingent equity securities	`GainLossOnEquityReceivable`	$4.27M	USD	Annual
Gain on contingent equity securities	`GainLossOnEquityReceivable`	-	USD	Annual
Unrealized loss on investments	`UnrealizedGainLossFromInvestmentInEquitySecurities`	$-25.51M	USD	Annual
Unrealized loss on investments	`UnrealizedGainLossFromInvestmentInEquitySecurities`	$-10.85M	USD	Annual
Unrealized loss on investments	`UnrealizedGainLossFromInvestmentInEquitySecurities`	$-11.00K	USD	Annual
Gain from investment in warrants	`FairValueAdjustmentOfWarrants`	-	USD	Annual
Gain from investment in warrants	`FairValueAdjustmentOfWarrants`	-	USD	Annual
Gain from investment in warrants	`FairValueAdjustmentOfWarrants`	$-1.15M	USD	Annual
Loss (income) from equity method investments, net	`IncomeLossFromEquityMethodInvestments`	$5.62M	USD	Annual
Loss (income) from equity method investments, net	`IncomeLossFromEquityMethodInvestments`	$3.69M	USD	Annual
Loss (income) from equity method investments, net	`IncomeLossFromEquityMethodInvestments`	$-4.31M	USD	Annual
Impairment of beneficial interest	`OtherAssetImpairmentCharges`	-	USD	Annual
Impairment of beneficial interest	`OtherAssetImpairmentCharges`	-	USD	Annual
Impairment of beneficial interest	`OtherAssetImpairmentCharges`	$15.72M	USD	Annual
Unrealized (gain) loss on interest rate swaps	`UnrealizedGainLossOnDerivatives`	$-1.07M	USD	Annual
Unrealized (gain) loss on interest rate swaps	`UnrealizedGainLossOnDerivatives`	-	USD	Annual
Unrealized (gain) loss on interest rate swaps	`UnrealizedGainLossOnDerivatives`	$4.24M	USD	Annual
Loss of disposal of property and equipment	`GainLossOnSaleOfPropertyPlantEquipment`	-	USD	Annual
Loss of disposal of property and equipment	`GainLossOnSaleOfPropertyPlantEquipment`	-	USD	Annual
Loss of disposal of property and equipment	`GainLossOnSaleOfPropertyPlantEquipment`	$-91.00K	USD	Annual
Deferred tax	`DeferredIncomeTaxesAndTaxCredits`	$-5.95M	USD	Annual
Deferred tax	`DeferredIncomeTaxesAndTaxCredits`	$-7.68M	USD	Annual
Deferred tax	`DeferredIncomeTaxesAndTaxCredits`	$-6.62M	USD	Annual
Other	`ProceedsFromOtherOperatingActivities`	$189.00K	USD	Annual
Other	`ProceedsFromOtherOperatingActivities`	-	USD	Annual
Other	`ProceedsFromOtherOperatingActivities`	-	USD	Annual
Receivable, net	`IncreaseDecreaseInAccountsReceivable`	$1.52M	USD	Annual
Receivable, net	`IncreaseDecreaseInAccountsReceivable`	$-4.13M	USD	Annual
Receivable, net	`IncreaseDecreaseInAccountsReceivable`	$41.19M	USD	Annual
Receivable, net related parties	`IncreaseDecreaseInDueFromRelatedParties`	$1.12M	USD	Annual
Receivable, net related parties	`IncreaseDecreaseInDueFromRelatedParties`	$20.12M	USD	Annual
Receivable, net related parties	`IncreaseDecreaseInDueFromRelatedParties`	$-4.23M	USD	Annual
Other receivable	`IncreaseDecreaseInOtherReceivables`	$-12.59M	USD	Annual
Other receivable	`IncreaseDecreaseInOtherReceivables`	$5.35M	USD	Annual
Other receivable	`IncreaseDecreaseInOtherReceivables`	$-8.20M	USD	Annual
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidExpensesAndOtherCurrentAssets`	$-818.00K	USD	Annual
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidExpensesAndOtherCurrentAssets`	$6.43M	USD	Annual
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidExpensesAndOtherCurrentAssets`	$-2.71M	USD	Annual
Right-of-use assets	`IncreaseDecreaseInOperatingLeaseAssets`	$3.76M	USD	Annual
Right-of-use assets	`IncreaseDecreaseInOperatingLeaseAssets`	$3.13M	USD	Annual
Right-of-use assets	`IncreaseDecreaseInOperatingLeaseAssets`	$3.33M	USD	Annual
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$1.53M	USD	Annual
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$5.53M	USD	Annual
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$243.00K	USD	Annual
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$8.20M	USD	Annual
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$3.22M	USD	Annual
Accounts payable and accrued expenses	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-49.00K	USD	Annual
Fiduciary accounts payable	`IncreaseDecreaseInOtherAccountsPayable`	$892.00K	USD	Annual
Fiduciary accounts payable	`IncreaseDecreaseInOtherAccountsPayable`	$7.62M	USD	Annual
Fiduciary accounts payable	`IncreaseDecreaseInOtherAccountsPayable`	$-2.47M	USD	Annual
Medical liabilities	`IncreaseDecreaseInMedicalLiabilities`	$25.78M	USD	Annual
Medical liabilities	`IncreaseDecreaseInMedicalLiabilities`	$-8.69M	USD	Annual
Medical liabilities	`IncreaseDecreaseInMedicalLiabilities`	$5.28M	USD	Annual
Income taxes payable	`IncreaseDecreaseInAccruedIncomeTaxesPayable`	$-304.00K	USD	Annual
Income taxes payable	`IncreaseDecreaseInAccruedIncomeTaxesPayable`	$-4.47M	USD	Annual
Income taxes payable	`IncreaseDecreaseInAccruedIncomeTaxesPayable`	$-3.62M	USD	Annual
Operating lease liabilities	`IncreaseDecreaseInOtherOperatingLeaseLiabilities`	$-3.94M	USD	Annual
Operating lease liabilities	`IncreaseDecreaseInOtherOperatingLeaseLiabilities`	$-3.21M	USD	Annual
Operating lease liabilities	`IncreaseDecreaseInOtherOperatingLeaseLiabilities`	$-2.97M	USD	Annual
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$82.13M	USD	Annual
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$46.16M	USD	Annual
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$70.33M	USD	Annual
Payments for business acquisition, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$11.35M	USD	Annual
Payments for business acquisition, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$16.35M	USD	Annual
Payments for business acquisition, net of cash acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$2.58M	USD	Annual
Proceeds from repayment of loans receivable - related parties	`ProceedsFromCollectionOfLongtermLoansToRelatedParties`	$16.50M	USD	Annual
Proceeds from repayment of loans receivable - related parties	`ProceedsFromCollectionOfLongtermLoansToRelatedParties`	$56.00K	USD	Annual
Proceeds from repayment of loans receivable - related parties	`ProceedsFromCollectionOfLongtermLoansToRelatedParties`	$4.07M	USD	Annual
Advances on loans receivable	`PaymentsToFundLongtermLoansToRelatedParties`	-	USD	Annual
Advances on loans receivable	`PaymentsToFundLongtermLoansToRelatedParties`	-	USD	Annual
Advances on loans receivable	`PaymentsToFundLongtermLoansToRelatedParties`	$145.00K	USD	Annual
Purchases of marketable securities	`PaymentsToAcquireMarketableSecurities`	$1.79M	USD	Annual
Purchases of marketable securities	`PaymentsToAcquireMarketableSecurities`	$1.85M	USD	Annual
Purchases of marketable securities	`PaymentsToAcquireMarketableSecurities`	$28.00M	USD	Annual
Purchases of investments equity method	`PaymentsToAcquireEquityMethodInvestments`	-	USD	Annual
Purchases of investments equity method	`PaymentsToAcquireEquityMethodInvestments`	$13.62M	USD	Annual
Purchases of investments equity method	`PaymentsToAcquireEquityMethodInvestments`	$9.97M	USD	Annual
Proceeds from sale of equity method investment	`ProceedsFromSaleOfEquityMethodInvestments`	-	USD	Annual
Proceeds from sale of equity method investment	`ProceedsFromSaleOfEquityMethodInvestments`	$52.74M	USD	Annual
Proceeds from sale of equity method investment	`ProceedsFromSaleOfEquityMethodInvestments`	$6.38M	USD	Annual
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$19.22M	USD	Annual
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$1.16M	USD	Annual
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$22.94M	USD	Annual
Proceeds from sale of fixed assets	`ProceedsFromSaleOfPropertyPlantAndEquipment`	$50.00K	USD	Annual
Proceeds from sale of fixed assets	`ProceedsFromSaleOfPropertyPlantAndEquipment`	-	USD	Annual
Proceeds from sale of fixed assets	`ProceedsFromSaleOfPropertyPlantAndEquipment`	-	USD	Annual
Proceeds from sale of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$31.67M	USD	Annual
Proceeds from sale of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$50.62M	USD	Annual
Proceeds from sale of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$67.61M	USD	Annual
Cash recorded from consolidation of VIE	`ProceedsFromCashReceivedFromConsolidationOfVariableInterestEntity`	-	USD	Annual
Cash recorded from consolidation of VIE	`ProceedsFromCashReceivedFromConsolidationOfVariableInterestEntity`	-	USD	Annual
Cash recorded from consolidation of VIE	`ProceedsFromCashReceivedFromConsolidationOfVariableInterestEntity`	$5.93M	USD	Annual
Distribution from investment - equity method	`ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital`	$400.00K	USD	Annual
Distribution from investment - equity method	`ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital`	-	USD	Annual
Distribution from investment - equity method	`ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital`	-	USD	Annual
Contribution to investment - equity method	`PaymentsToEquityMethodInvestments`	-	USD	Annual
Contribution to investment - equity method	`PaymentsToEquityMethodInvestments`	-	USD	Annual
Contribution to investment - equity method	`PaymentsToEquityMethodInvestments`	$2.10M	USD	Annual
Net cash (used in) provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$16.54M	USD	Annual
Net cash (used in) provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-7.11M	USD	Annual
Net cash (used in) provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$95.49M	USD	Annual
Dividends paid	`PaymentsOfDividendsCommonStock`	$31.09M	USD	Annual
Dividends paid	`PaymentsOfDividendsCommonStock`	$14.03M	USD	Annual
Dividends paid	`PaymentsOfDividendsCommonStock`	$51.32M	USD	Annual
Repayments on long-term debt	`RepaymentsOfOtherLongTermDebt`	$3.87M	USD	Annual
Repayments on long-term debt	`RepaymentsOfOtherLongTermDebt`	$238.33M	USD	Annual
Repayments on long-term debt	`RepaymentsOfOtherLongTermDebt`	$9.50M	USD	Annual
Payment of finance lease obligations	`RepaymentsOfDebtAndCapitalLeaseObligations`	$561.00K	USD	Annual
Payment of finance lease obligations	`RepaymentsOfDebtAndCapitalLeaseObligations`	$208.00K	USD	Annual
Payment of finance lease obligations	`RepaymentsOfDebtAndCapitalLeaseObligations`	$105.00K	USD	Annual
Proceeds from exercise of stock options and warrants	`ProceedsFromWarrantExercises`	$10.80M	USD	Annual
Proceeds from exercise of stock options and warrants	`ProceedsFromWarrantExercises`	$9.06M	USD	Annual
Proceeds from exercise of stock options and warrants	`ProceedsFromWarrantExercises`	$8.63M	USD	Annual
Repurchase of common stock	`PaymentsForRepurchaseOfCommonStock`	$5.74M	USD	Annual
Repurchase of common stock	`PaymentsForRepurchaseOfCommonStock`	$537.00K	USD	Annual
Repurchase of common stock	`PaymentsForRepurchaseOfCommonStock`	$9.25M	USD	Annual
Proceeds from sale of common stock	`ProceedsFromIssuanceOfCommonStock`	-	USD	Annual
Proceeds from sale of common stock	`ProceedsFromIssuanceOfCommonStock`	-	USD	Annual
Proceeds from sale of common stock	`ProceedsFromIssuanceOfCommonStock`	$40.13M	USD	Annual
Purchase of non-controlling interest	`PaymentsOfDividendsMinorityInterest`	$5.05M	USD	Annual
Purchase of non-controlling interest	`PaymentsOfDividendsMinorityInterest`	$1.47M	USD	Annual
Purchase of non-controlling interest	`PaymentsOfDividendsMinorityInterest`	$1.04M	USD	Annual
Proceeds from sale of noncontrolling interest	`ProceedsFromPaymentsToMinorityShareholders`	-	USD	Annual
Proceeds from sale of noncontrolling interest	`ProceedsFromPaymentsToMinorityShareholders`	$48.00K	USD	Annual
Proceeds from sale of noncontrolling interest	`ProceedsFromPaymentsToMinorityShareholders`	$436.00K	USD	Annual
Borrowings on loans	`ProceedsFromIssuanceOfOtherLongTermDebt`	$180.57M	USD	Annual
Borrowings on loans	`ProceedsFromIssuanceOfOtherLongTermDebt`	-	USD	Annual
Borrowings on loans	`ProceedsFromIssuanceOfOtherLongTermDebt`	$3.60M	USD	Annual
Cost of debt and equity issuances	`PaymentOfFinancingAndStockIssuanceCosts`	-	USD	Annual
Cost of debt and equity issuances	`PaymentOfFinancingAndStockIssuanceCosts`	-	USD	Annual
Cost of debt and equity issuances	`PaymentOfFinancingAndStockIssuanceCosts`	$727.00K	USD	Annual
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-20.09M	USD	Annual
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-51.70M	USD	Annual
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-47.75M	USD	Annual
Net increase in cash, cash equivalents, and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$39.13M	USD	Annual
Net increase in cash, cash equivalents, and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$89.96M	USD	Annual
Net increase in cash, cash equivalents, and restricted cash	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$54.93M	USD	Annual
Cash, cash equivalents, and restricted cash, beginning of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$193.97M	USD	Point-in-time
Cash, cash equivalents, and restricted cash, beginning of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$104.01M	USD	Point-in-time
Cash, cash equivalents, and restricted cash, beginning of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$233.10M	USD	Point-in-time
Cash, cash equivalents, and restricted cash, beginning of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$288.03M	USD	Point-in-time
Cash, cash equivalents and restricted cash, end of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$193.97M	USD	Point-in-time
Cash, cash equivalents and restricted cash, end of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$104.01M	USD	Point-in-time
Cash, cash equivalents and restricted cash, end of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$233.10M	USD	Point-in-time
Cash, cash equivalents and restricted cash, end of year	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$288.03M	USD	Point-in-time
Cash paid for income taxes	`IncomeTaxesPaid`	$47.31M	USD	Annual
Cash paid for income taxes	`IncomeTaxesPaid`	$62.00M	USD	Annual
Cash paid for income taxes	`IncomeTaxesPaid`	$37.20M	USD	Annual
Cash paid for interest	`InterestPaidNet`	$4.16M	USD	Annual
Cash paid for interest	`InterestPaidNet`	$6.67M	USD	Annual
Cash paid for interest	`InterestPaidNet`	$8.51M	USD	Annual
Dividend declared included in dividend payable	`DividendsPayableCurrentAndNoncurrent`	$71.00K	USD	Point-in-time
Dividend declared included in dividend payable	`DividendsPayableCurrentAndNoncurrent`	-	USD	Point-in-time
Dividend declared included in dividend payable	`DividendsPayableCurrentAndNoncurrent`	$485.00K	USD	Point-in-time
Issuance of financing obligation for business combinations	`IssuanceOfFinancingObligationForBusinessCombination`	-	USD	Annual
Issuance of financing obligation for business combinations	`IssuanceOfFinancingObligationForBusinessCombination`	$12.71M	USD	Annual
Issuance of financing obligation for business combinations	`IssuanceOfFinancingObligationForBusinessCombination`	-	USD	Annual
Cashless exercise of warrants	`CashlessExerciseOfStockOptions`	$599.00K	USD	Annual
Cashless exercise of warrants	`CashlessExerciseOfStockOptions`	$694.00K	USD	Annual
Cashless exercise of warrants	`CashlessExerciseOfStockOptions`	-	USD	Annual
Fixed asset obtained in exchange for finance lease liabilities	`FixedAssetObtainedInExchangeForFinanceLeaseLiabilities`	$971.00K	USD	Annual
Fixed asset obtained in exchange for finance lease liabilities	`FixedAssetObtainedInExchangeForFinanceLeaseLiabilities`	-	USD	Annual
Fixed asset obtained in exchange for finance lease liabilities	`FixedAssetObtainedInExchangeForFinanceLeaseLiabilities`	-	USD	Annual
Common stock issued in business combination	`StockIssued1`	-	USD	Annual
Common stock issued in business combination	`StockIssued1`	$1.00M	USD	Annual
Common stock issued in business combination	`StockIssued1`	-	USD	Annual
Mortgage loan	`MortgageLoanRelatedToPropertySales1`	$16.27M	USD	Annual
Mortgage loan	`MortgageLoanRelatedToPropertySales1`	-	USD	Annual
Mortgage loan	`MortgageLoanRelatedToPropertySales1`	-	USD	Annual
Cancellation of Restricted Stock Awards	`CancellationOfRestrictedStockAwards`	$334.00K	USD	Annual
Cancellation of Restricted Stock Awards	`CancellationOfRestrictedStockAwards`	-	USD	Annual
Cancellation of Restricted Stock Awards	`CancellationOfRestrictedStockAwards`	-	USD	Annual
Deferred tax liability adjustment related to warrant exercises	`AdjustmentOfWarrantsGrantedForServices`	-	USD	Annual
Deferred tax liability adjustment related to warrant exercises	`AdjustmentOfWarrantsGrantedForServices`	-	USD	Annual
Deferred tax liability adjustment related to warrant exercises	`AdjustmentOfWarrantsGrantedForServices`	$690.00K	USD	Annual
Preferred shares received from sale of equity method investment	`ConversionOfStockAmountIssued1`	-	USD	Annual
Preferred shares received from sale of equity method investment	`ConversionOfStockAmountIssued1`	-	USD	Annual
Preferred shares received from sale of equity method investment	`ConversionOfStockAmountIssued1`	$36.18M	USD	Annual
Beneficial interest acquired from sale of equity method investment	`ConsiderationReceivedForBeneficialInterestObtainedForTransferringFinancialAsset`	-	USD	Annual
Beneficial interest acquired from sale of equity method investment	`ConsiderationReceivedForBeneficialInterestObtainedForTransferringFinancialAsset`	-	USD	Annual
Beneficial interest acquired from sale of equity method investment	`ConsiderationReceivedForBeneficialInterestObtainedForTransferringFinancialAsset`	$15.72M	USD	Annual
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$288.03M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$233.10M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$193.47M	USD	Point-in-time
Restricted cash long-term - letters of credit	`RestrictedCashEquivalentsNoncurrent`	-	USD	Point-in-time
Restricted cash long-term - letters of credit	`RestrictedCashEquivalentsNoncurrent`	-	USD	Point-in-time
Restricted cash long-term - letters of credit	`RestrictedCashEquivalentsNoncurrent`	$500.00K	USD	Point-in-time
Total cash, cash equivalents, and restricted cash shown in the statement of cash flows	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$193.97M	USD	Point-in-time
Total cash, cash equivalents, and restricted cash shown in the statement of cash flows	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$104.01M	USD	Point-in-time
Total cash, cash equivalents, and restricted cash shown in the statement of cash flows	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$233.10M	USD	Point-in-time
Total cash, cash equivalents, and restricted cash shown in the statement of cash flows	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$288.03M	USD	Point-in-time

Stockholders Equity 47 line items

Line Item	Tag	Value	Unit	Period
Temporary equity, carrying amount, beginning balance	`TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests`	$13.68M	USD	Point-in-time
Temporary equity, carrying amount, beginning balance	`TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests`	$55.51M	USD	Point-in-time
Purchase of non-controlling interest	`MinorityInterestDecreaseFromRedemptions`	$75.00K	USD	Annual
Purchase of non-controlling interest	`MinorityInterestDecreaseFromRedemptions`	$4.34M	USD	Annual
Temporary equity, carrying amount, ending balance	`TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests`	$13.68M	USD	Point-in-time
Temporary equity, carrying amount, ending balance	`TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests`	$55.51M	USD	Point-in-time
Balance at beginning (in shares)	`SharesOutstanding`	46.58M	shares	Point-in-time
Balance at beginning (in shares)	`SharesOutstanding`	44.63M	shares	Point-in-time
Balance at beginning	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$192.34M	USD	Point-in-time
Balance at beginning	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$555.01M	USD	Point-in-time
Balance at beginning	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$330.91M	USD	Point-in-time
Balance at beginning	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$460.49M	USD	Point-in-time
Net income	`NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity`	$38.70M	USD	Annual
Net income	`NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity`	$76.62M	USD	Annual
Net income	`NetIncomeLossIncludingPortionAttributableToNoncontrollingInterestAndTemporaryEquity`	$53.26M	USD	Annual
Purchase of treasury shares	`TreasuryStockValueAcquiredParValueMethod`	$9.25M	USD	Annual
Purchase of treasury shares	`TreasuryStockValueAcquiredParValueMethod`	$301.00K	USD	Annual
Purchase of treasury shares	`TreasuryStockValueAcquiredParValueMethod`	$5.74M	USD	Annual
Purchase of noncontrolling interest	`MinorityInterestDecreaseFromRedemptions`	$75.00K	USD	Annual
Purchase of noncontrolling interest	`MinorityInterestDecreaseFromRedemptions`	$4.34M	USD	Annual
Sale of shares by noncontrolling interest	`StockIssuedDuringPeriodValueNoncontrollingInterest`	$40.13M	USD	Annual
Sale of non-controlling interest	`NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest`	$66.00K	USD	Annual
Shares issued for vesting of restricted stock awards	`StockIssuedDuringPeriodValueRestrictedStockAwardGross`	$-321.00K	USD	Annual
Shares issued for cash and exercise of options and warrants	`StockIssuedDuringThePeriodValueOfExerciseOfOptionAndWarrants`	$9.06M	USD	Annual
Shares issued for cash and exercise of options and warrants	`StockIssuedDuringThePeriodValueOfExerciseOfOptionAndWarrants`	$8.63M	USD	Annual
Shares issued for cash and exercise of options and warrants	`StockIssuedDuringThePeriodValueOfExerciseOfOptionAndWarrants`	$11.49M	USD	Annual
Share-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$6.75M	USD	Annual
Share-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$3.38M	USD	Annual
Share-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$16.10M	USD	Annual
Issuance of shares for business acquisition	`StockIssuedDuringPeriodValueAcquisitions`	$1.00M	USD	Annual
Investment in non-controlling interest	`NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance`	$371.00K	USD	Annual
Investment in non-controlling interest	`NoncontrollingInterestIncreaseFromSubsidiaryEquityIssuance`	$3.77M	USD	Annual
Acquisition of non-controlling interest	`NoncontrollingInterestIncreaseFromBusinessCombination`	$500.00K	USD	Annual
Cancellation of restricted stock awards	`StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures`	$236.00K	USD	Annual
Cancellation of restricted stock awards	`StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures`	$334.00K	USD	Annual
Cancellation of restricted stock awards	`StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures`	$457.00K	USD	Annual
Non-controlling interest capital change	`NoncontrollingInterestIncreaseFromCapitalCharge`	$48.00K	USD	Annual
AAMG stock contingent consideration (see Note 3)	`AAMGEquityContingentConsideration`	$5.57M	USD	Annual
Dividends	`NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodValueReleaseOfHoldBackShares`	$-1.16M	USD	Annual
Dividends	`NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodValueReleaseOfHoldBackShares`	$85.54M	USD	Annual
Dividends	`NoncontrollingInterestDecreaseFromDistributionsToNoncontrollingInterestHoldersAndStockRepurchasedDuringPeriodValueReleaseOfHoldBackShares`	$23.89M	USD	Annual
Balance at ending (in shares)	`SharesOutstanding`	46.58M	shares	Point-in-time
Balance at ending (in shares)	`SharesOutstanding`	44.63M	shares	Point-in-time
Balance at ending	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$192.34M	USD	Point-in-time
Balance at ending	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$555.01M	USD	Point-in-time
Balance at ending	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$330.91M	USD	Point-in-time
Balance at ending	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$460.49M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.